Poly(l-aspartic acid) derivative soluble in a volatile organic solvent for biomedical application

Colloids and Surfaces B: Biointerfaces

Volumn 97, Issue , 2012, Pages 190-195

  Oh, Nam Muk ^a   Oh, Kyung Taek ^b   Youn, Yu Seok ^c   Lee, Eun Seong ^a  

^a The Catholic University of Korea   (South Korea)

^b Chung Ang University   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Diethylaminopropyl group; PH sensitive polymer; Poly(l aspartic acid) derivative; Volatile solvent

Indexed keywords

BIOMEDICAL APPLICATIONS; CARBOXYLATE GROUPS; DIETHYLAMINOPROPYL GROUP; DOXORUBICIN; DRUG CARRIER; DRUG MOLECULES; HIGH SOLUBILITY; L-AMINO ACIDS; L-ASPARTIC ACID; MODEL DRUGS; NANO-SIZED PARTICLES; PH SENSITIVE; POLYMERIC MICELLE; STIMULI-SENSITIVE; VOLATILE ORGANIC SOLVENTS; VOLATILE SOLVENTS;

ACETONE; CARBOXYLATION; DICHLOROMETHANE; MEDICAL APPLICATIONS; MICELLES; ORGANIC SOLVENTS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMERIC FILMS;

AMINO ACIDS;

ACETONE; CARBOXYLIC ACID; CHLOROFORM; DICHLOROMETHANE; DOXORUBICIN; NANOMATERIAL; ORGANIC SOLVENT; POLYASPARTIC ACID; POLYASPARTIC ACID G 3 DIETHYLAMINOPROPYL B MACROGOL; UNCLASSIFIED DRUG; VOLATILE ORGANIC SOLVENT;

ARTICLE; BIOMEDICINE; CONJUGATION; DRUG RELEASE; ENCAPSULATION; MICELLIZATION; NANOFABRICATION; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON TRANSPORT; SOLUBILITY;

ASPARTIC ACID; DOXORUBICIN; DRUG CARRIERS; HYDROGEN-ION CONCENTRATION; MICELLES; POLYMERS; SOLUBILITY; SOLVENTS;

EID: 84861046005     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.03.024     Document Type: Article

References (26)

1. Brown M., Schätzlein A., Brownlie A., Jack V., Wang W., Tetley L., Gray A., Uchegbu I. Bioconjug. Chem. 2000, 11:880-891.
2. Oh K.T., Baik H.J., Lee A.H., Oh Y.T., Youn Y.S., Lee E.S. Int. J. Mol. Sci. 2009, 10:3776-3792.
3. Wang Y., Chandra R., Samsa L.A., Gooch B., Fee B.E., Cook J.M., Vigna S.R., Grant A.O., Liddle R.A. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:528-537.
4. Lee E.S., Gao Z., Bae Y.H. J. Control. Release 2008, 132:164-170.
5. Tansey W., Ke S., Cao X.Y., Pasuelo M.J., Wallace S., Li C. J. Control. Release 2004, 94:39-51.
6. D'Addio S.M., Prud'home R.K. Adv. Drug Deliv. Rev. 2011, 63:417-426.
7. Kwon G.S., Forrest M.L. Drug Dev. Res. 2006, 67:15-22.
8. Tyrrell Z.L., Shen Y., Radosz M. Prog. Polym. Sci. 2010, 35:1128-1143.
9. Meng F., Zhong Z., Feijen J. Biomacromolecules 2009, 10:197-209.
10. Delie F., Blanco-Príeto M.J. Molecules 2005, 10:65-80.
11. Yuan M., Deng X. Eur. Polym. J. 2001, 37:1907-1912.
12. Lee E.S., Na K., Bae Y.H. Nano Lett. 2005, 5:325-329.
13. Park S.Y., Baik H.J., Oh Y.T., Oh K.T., Youn Y.S., Lee E.S. Angew. Chem. Int. Ed. 2011, 50:1644-1647.
14. Oh N.M., Oh K.T., Baik H.J., Lee B.R., Lee A.H., Youn Y.S., Lee E.S. Colloids Surf. B: Biointerfaces 2010, 78:120-126.
15. Lee B.R., Oh K.T., Oh Y.T., Baik H.J., Park S.Y., Youn Y.S., Lee E.S. Chem. Commun. 2011, 47:3852-3854.
16. Lee E.S., Kim D., Youn Y.S., Oh K.T., Bae Y.H. Angew. Chem. Int. Ed. 2008, 120:2452-2455.
17. Gao Z., Lee D., Kim D., Bae Y. J. Drug Target. 2005, 13:391-397.
18. Gullotti E., Yeo Y. Mol. Pharm. 2009, 6:1041-1051.
19. Höckel M., Vaupel P. J. Natl. Cancer Inst. 2001, 93:266-281.
20. Rapoport N.Y., Kennedy A.M., Shea J.E., Scaife C.L., Nam K.H. J. Control. Release 2009, 138:268-276.
21. Berger A., Katchalski E. J. Am. Chem. Soc. 1951, 73:4084-4088.
22. Lee J.C., Bermudez H., Discher B.M., Sheehan M.A., Won Y.Y., Bates F.S., Discher D.E. Biotechnol. Bioeng. 2001, 73:135-145.
23. Riley T., Stolnik S., Heald C., Xiong C., Garnett M., Illum L., Davis S., Purkiss S., Barlow R., Gellert P. Langmuir 2001, 17:3168-3174.
24. Tifany M.L., Krimm S. Biopolymers 1972, 11:2309-2316.
25. Greenfield N.J. Nat. Protoc. 2006, 1:2876-2890.
26. Lee E.S., Youn Y.S. Bull. Korean Chem. Soc. 2008, 29:1539-1544.